Essay - Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of...


1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Copyright Notice

Pfizer SWOT

Pfizer—a SWOT Analysis

Strengths

Pfizer is one of the world's leading research pharmaceutical companies and also one ***** the world's most profitable companies. It has a well-respected name known all over the world and comm*****s some of ***** top research, advertising, financial, and marketing talent. ***** produces two of the most well-known name-brand drugs, Viagra and Lipitor in America today. Even the American Heart Association recommends the use of ***** such as Lipitor to reduce cholesterol when diet and exercise fail ***** reduce this common health problem. High ***** ***** a common ***** problem is only likely to *****crease with the rapidly aging population—and the rise in obesity levels (Berenson, 2007).

Weaknesses

Unfortunately, "while the company remains highly profitable, its financial health is increasingly tied to Lipi*****r" which is dangerous for the ***** in ***** future as Lipitor's patent will expire in several years, which means it will face competition from cheaper, generic drugs (*****, 2007). Pfizer's reputation has ***** been ta*****ted by its association with Celebrex, a pain medication that has been tied to increased risk of heart problems, in comparison to over-the-counter painkillers. The prominence of the Pfizer advertising campaign for ***** drug, followed by its rapid f***** *****rom grace undoubtedly damaged the company's trusted name.

Pfizer also manufactures Zol*****t, an antidepressant that was widely criticized for ***** over-prescription to teenager, and possibly causing increased suicidal thoughts in this population. ***** company website now states that the drug is not advised for people under the age of 17. Antidepressants and 'lifestyle' drugs like Viagra have come under *****creased media scrutiny and *****d as examples of the over-prescription of medication in the American healthcare system ***** general. Healthcare in America is grow*****g more and ***** expensive, and insurance companies are being pressured to cut costs, including scaling back how much they pay ***** drugs.

Now, Exubera, "the first ***** so far only commercially available inhaled-insulin diabetes treatment," ***** on the verge ***** turning in***** an "expensive failure" as Pfizer "has been dogged by questi*****s about its safety, cost and convenience" (Berenson, 2007).

Opportunities

According to the ***** press release section of its website, discomfort associated with fibromyaglia, a ***** chronic pain condition, has been shown ***** be significantly reduced ***** a new drug developed by Pfizer called Lyrica, "according to study results presented today at the ***** Academy ***** Neurology annual meeting" ("Lyrica Significantly Reduced Pain," 2007, Press Release). Pfizer has also developed a new AIDS ***** called Maraviroc, which is likely to considerably improve ***** extend the life of AIDS p*****ients who take the drug, ***** to ********** at ***** University of Pittsburg and Columbia University (Altman & Pollock, *****).

Threats

***** Merck ***** Schering-Plough, two of Pfizer's greatest rivals, plan to combine forces and develop a medicine to rival Lipitor. "The planned drug, meant to reduce levels of the harmful type of cholesterol in two ways, could hit the market when Lipi*****r's patent expires in a few years" ("Merck and Schering-Plough Plan Ano*****r Cholesterol Drug,"

. . . . [END OF TERM PAPER PREVIEW]

Download full paper (and others like it)    |    Order a brand new, customized paper

© 2001–2017   |   Book Report on Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of   |   Dissertations Examples